Clinic
Cookeville Medical Center PC
Cookeville Medical Center PC was paid $1.21M by Medicaid between Jan 2018 and Dec 2024, across 89 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 18% of everything it billed.
33Billing provider infoCOOKEVILLE MEDICAL CENTER PC
COOKEVILLE, TN 38501
COOKEVILLE, TN 38501
33aNPI1013055912assigned 02/02/2007
33bProvider typeRadiology Clinic/Center
28Total paid$1.21M
24GClaims114,256
24DCodes billed89
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Radiology Clinic/Center providers in Tennessee
Rank by total paid#1 of 5
Median peer was paid$28K
This provider vs. median43×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,559 | $360K | |
| 2019 | 13,739 | $97K | |
| 2020 | 18,823 | $185K | |
| 2021 | 22,409 | $294K | |
| 2022 | 14,794 | $172K | |
| 2023 | 12,185 | $71K | |
| 2024incomplete | 6,747 | $32K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 18% | 7,494 | 5,095 | $215K |
| 87428 | 13% | 3,638 | 2,978 | $162K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 11% | 4,965 | 2,999 | $131K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 5.7% | 5,666 | 3,955 | $69K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 5.2% | 665 | 468 | $64K |
| 71046 | Radiologic examination, chest; 2 views | 4.9% | 5,826 | 4,044 | $59K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 4.4% | 718 | 404 | $53K |
| 94060 | 3.8% | 2,390 | 1,697 | $46K | |
| 93000 | 3.6% | 5,797 | 3,952 | $44K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.5% | 10,964 | 8,291 | $43K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.1% | 2,028 | 1,321 | $38K |
| 80305 | 2.7% | 9,171 | 7,221 | $32K |
77 more codes
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.9% | 2,065 | $23K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1.6% | 334 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.4% | 1,976 | $17K |
| 72100 | 1.3% | 1,174 | $15K | |
| 71250 | 1.1% | 574 | $14K | |
| 93880 | <1% | 516 | $12K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 13,775 | $11K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,730 | $11K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 178 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,437 | $10K |
| 81003 | <1% | 8,542 | $8K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,961 | $8K |
| 80061 | Lipid panel | <1% | 2,398 | $7K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 58 | $7K |
| 86328 | <1% | 251 | $6K | |
| 77080 | <1% | 389 | $6K | |
| 74018 | <1% | 485 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 67 | $5K |
| 73562 | <1% | 290 | $4K | |
| 76775 | <1% | 391 | $4K | |
| 93922 | <1% | 372 | $3K | |
| 3008F | <1% | 5,907 | $3K | |
| 95923 | <1% | 298 | $3K | |
| 0011A | <1% | 127 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 169 | $3K |
| 0031A | <1% | 100 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 75 | $3K |
| 0012A | <1% | 87 | $2K | |
| 84439 | <1% | 791 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 276 | $2K |
| 80076 | <1% | 813 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,120 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 838 | $2K |
| 90756 | <1% | 118 | $2K | |
| 72040 | <1% | 112 | $1K | |
| 93925 | <1% | 45 | $1K | |
| 99050 | <1% | 150 | $1K | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 422 | $1K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 197 | $1K |
| 87210 | <1% | 447 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 491 | $949.49 |
| 73030 | <1% | 71 | $924.56 | |
| 73630 | <1% | 63 | $851.52 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 30 | $739.73 |
| 95921 | <1% | 175 | $713.98 | |
| 93015 | <1% | 15 | $647.11 | |
| 76536 | <1% | 16 | $611.64 | |
| 72131 | <1% | 26 | $606.81 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 20 | $422.90 |
| 92250 | <1% | 46 | $419.64 | |
| 73610 | <1% | 31 | $413.38 | |
| 80050 | General health panel | <1% | 41 | $386.62 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 271 | $347.09 |
| 81025 | <1% | 62 | $320.65 | |
| 94690 | <1% | 13 | $301.99 | |
| 94760 | <1% | 277 | $251.05 | |
| 90674 | <1% | 36 | $226.33 | |
| 87275 | <1% | 45 | $208.68 | |
| 3079F | <1% | 56 | $140.00 | |
| 90686 | <1% | 29 | $131.31 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 137 | $126.82 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 15 | $117.30 |
| 85651 | <1% | 97 | $116.72 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 514 | $106.27 |
| 95117 | <1% | 17 | $94.52 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 561 | $73.02 |
| 3074F | <1% | 36 | $70.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 37 | $65.24 |
| 81002 | <1% | 36 | $38.50 | |
| G0008 | Administration of influenza virus vaccine | <1% | 128 | $17.25 |
| 82947 | <1% | 24 | $9.40 | |
| 91303 | <1% | 105 | $1.90 | |
| 91301 | <1% | 214 | $0.36 | |
| 90662 | 0% | 38 | $0.00 | |
| 90653 | 0% | 14 | $0.00 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 0% | 51 | $0.00 |
| 2022F | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJAIN, PUSHPENDRA (CEO)
| Provider | Location | Paid |
|---|---|---|
| Upper Cumberland Rural Health Clinic PLLC | Cookeville, TN | $3.60M |
| Emergency Services Corporation of America | Cookeville, TN | $248K |
| Upper Cumberland Rural Health Clinic PLLC | Gainesboro, TN | $110.92 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.